Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLU-5937 in chronic pruritus with atopic dermatitis
NCT04693195Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of camlipixant in chronic pruritus (CP), sponsored by GSK. Started Dec 2020; status: completed.
02
Drugs
camlipixant
03
Conditions
chronic pruritus (CP)
Beyond the preview
Go deeper on NCT04693195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04693195.